Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Recipharm and CTC launch integrated first in human service

    Sep 12, 2017, 05:40 AM by Michael Croft
    - Sep 12, 2017 - Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch a new service that delivers a clear, streamlined pathway to first in human milestones
    Full story
  • Sam Beck, Ph.D., Joins MDI Biological Laboratory Faculty in Computational Biolog

    Sep 11, 2017, 11:15 AM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Sep 11, 2017 - The MDI Biological Laboratory has announced that Sam Beck, Ph.D., has joined the faculty as an assistant professor of computational biology
    Full story
  • ArisGlobal Announces LifeSphere Mobile MA™, Life Science’s First Multi-Function, Self-Service Portal for Medical Affairs and Pharmacovigilance

    Sep 11, 2017, 10:20 AM by Michael Croft
    MIAMI, FL, UNITED STATES - Sep 13, 2017 - ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences, today announced that LifeSphere Mobile MA™ is the first multi-lingual service portal and mobile app for medical affairs and pharmacovigilance to help sales reps, medical science liaisons (MSLs), healthcare professionals and even patients access approved product content, address adverse event management, and submit medical inquiries and product quality complaints from any mobile device
    Full story
  • Long-Read Sequencing Data Enables Structural Variant Discovery For Clinical And Disease Research

    Sep 11, 2017, 10:15 AM by Michael Croft

    Bio-IT World Contributed Commentary | The advent of single molecule, real-time sequencing, with average read lengths exceeding 12 kb, has allowed scientists to reliably detect structural variation for the first time. These latest studies have shown that previous human genome data sets have dramatically underrepresented the number of structural variants—along with their effect on health and disease.

    Full story
  • Ardena launches following Pharmavize and Crystallics merger

    Sep 11, 2017, 05:40 AM by Michael Croft
    - Sep 11, 2017 - A new early-phase contract development and manufacturing organisation (CDMO), Ardena, has launched following the merging of Pharmavize and Crystallics
    Full story
  • Amid Setback Researchers Forge Ahead with “Off-the-Shelf” Immune Cells to Treat Cancer

    Sep 8, 2017, 14:15 PM by Michael Croft
    MIT Technology Review | The approach could treat patients in dire need faster at a lower price, but major questions remain about safety.
    Full story
  • Genestack offers ‘missing link’ for genomics drug discovery

    Sep 8, 2017, 12:10 PM by Michael Croft
    CAMBRIDGE, UK - Sep 8, 2017 - “Genestack is providing an essential missing link between data and its analysis,” says Imad I. Yassin, recently appointed Vice President of Sales and Marketing for Genestack, the Cambridge-based biodata management company
    Full story
  • Patients Without Traditional Cancer Screening Find Allies In Maccabi And Medial EarlySign

    Sep 8, 2017, 08:45 AM by Michael Croft

    Bio-IT World | 2017 Best Practices Awards | Maccabi Healthcare System is using Medial EarlySign’s clinical decision support tool to find colon cancer patients among individuals who didn’t go through traditional channels for screening.

    Full story
  • Visualising gene-trait networks for faster discovery

    Sep 8, 2017, 07:57 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Sep 8, 2017 - It is now possible for non-bioinformaticians to create knowledge-networks – a powerful way for biologists to visualise deep connections between genes and phenotypes – quickly and efficiently thanks to the integration of Rothamsted Research’s open-source KnetMiner software into the Genestack platform
    Full story
  • Does Your Genome Predict Your Face? Not Quite Yet

    Sep 7, 2017, 12:50 PM by Michael Croft
    MIT Technology Review | Genomics pioneer J. Craig Venter says if he had your genome he could pick you out of a crowd. According to two experts who reviewed the famed genomics expert's claim, however, that's not necessarily true.
    Full story
  • BioIVT Acquires Qualyst Transporter Solutions, Enables Researchers to Predict New Drug Candidates’ Impact on the Liver

    Sep 7, 2017, 12:28 PM by Michael Croft
    WESTBURY, NY - Sep 7, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it has acquired Qualyst Transporter Solutions, LLC
    Full story
  • At Vanderbilt, NCI’s Cooperative Human Tissue Network Relies On Lean Principles For Efficiency

    Sep 7, 2017, 09:15 AM by Michael Croft

    Bio-IT World | The National Cancer Institute’s Cooperative Human Tissue Network (CHTN) provides human tissues and fluids from routine procedures to investigators who use human biospecimens in their research. Unlike tissue banks, the CHTN works prospectively with each investigator to tailor specimen acquisition and processing to meet their specific project requirements.

    Full story
  • IBM Pitched Watson As A Revolution In Cancer Care. It's Nowhere Close

    Sep 6, 2017, 11:35 AM by Michael Croft
    STAT | Three years after IBM began selling Watson for Oncology to recommend cancer treatments, it's falling short of the lofty expectations IBM created for it.
    Full story
  • FormulationX To Debut At INTERPHEX 2018; Elsevier A Foundation Sponsor

    Sep 6, 2017, 05:18 AM by Michael Croft
    NEW YORK, NY - Sep 5, 2017 - International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, today announced FormulationX will debut at INTERPHEX 2018 featuring exhibits, technical conference and networking focused on drug substance
    Full story
  • Human Longevity Researchers Use Whole Genome Sequence Data And Machine Learning To Identify Individuals Through Face And Other Physical Trait Prediction

    Sep 5, 2017, 10:50 AM by Michael Croft

    Bio-IT World Brief | Researchers from Human Longevity have published a study in which individual faces and other physical traits were predicted using whole genome sequencing data and machine learning. This work was published in the journal Proceedings from the National Academy of Sciences.

    Full story
  • MR Solutions receives second Queen’s Award from Lord-Lieutenant of Surrey

    Sep 4, 2017, 11:31 AM by Michael Croft
    , UNITED KINGDOM - Sep 4, 2017 - MR Solutions has received the prestigious Queen’s Award for Enterprise from the Lord-Lieutenant of Surrey at their Guildford headquarters in September in recognition of their outstanding success in growing international sales
    Full story
  • GenePattern Notebook Environment Needs Only A Web Browser To Run Analyses

    Aug 31, 2017, 16:05 PM by Michael Croft
    Bio-IT World Researchers at the University of California San Diego School of Medicine and the Broad Institute of MIT and Harvard have launched a new GenePattern Notebook environment, which combines the dynamic capabilities of an electronic analysis notebook with the ease of use of a point-and-click interface to hundreds of genomic tools.
    Full story
  • Renewed Attention Sees New Progress For Hepatitis B

    Aug 31, 2017, 11:40 AM by Michael Croft

    Bio-IT World | The HBV field has seen increased attention from industry research in the past few years, influenced by the success of new hepatitis C virus (HCV) therapies. After scientists realized HCV could be cured, they turned their attention to hepatitis B, hoping to develop a cure for it also.

    Full story
  • FDA Approval Brings First Gene Therapy To The United States

    Aug 30, 2017, 17:35 PM by Michael Croft

    Bio-IT World Brief | The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.

    Full story
  • Edico, DNAnexus Launch $20, 90-minute Whole Genome Analysis

    Aug 30, 2017, 16:20 PM by Michael Croft
    Bio-IT World Edico Genome and DNAnexus, Inc. today announced the availability of Edico Genome’s DRAGEN on Amazon Web Service’s EC2 F1/FPGA instances via DNAnexus. For a limited time, the cost to analyze a whole genome at 35X coverage will be $20 and take about an hour and a half, Pieter van Rooyen said.
    Full story
  • «
  • 291
  • 292
  • 293
  • 294
  • 295 (current)
  • 296
  • 297
  • 298
  • 299
  • 300
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy